Summary
Elevance Health, Inc. (then WellPoint, Inc.) issued this Form 8-K on September 10, 2008, primarily to reaffirm its full-year 2008 net income guidance of $5.42 to $5.57 per share. This reaffirmation comes despite an anticipated other-than-temporary impairment charge related to its investment in Fannie Mae and Freddie Mac perpetual preferred stock, which had declined in value by approximately $214 million as of September 8, 2008. The company expects these impairments to be offset by reserve releases stemming from newly entered settlement agreements with federal and state taxing authorities in the third quarter. Furthermore, the filing indicates that WellPoint's officers were scheduled to speak with securities analysts and investors between September 11 and September 24, 2008, during which they intended to reiterate the reaffirmed net income guidance. Investors should note that the company also provided a standard Safe Harbor Statement, outlining various risks and uncertainties that could impact future financial performance, including regulatory changes, healthcare cost trends, and market conditions.
Key Highlights
- 1Reaffirmed full-year 2008 net income guidance of $5.42 - $5.57 per share.
- 2Anticipates an other-than-temporary impairment charge on Fannie Mae and Freddie Mac perpetual preferred stock.
- 3The cost basis of the affected preferred stock was approximately $243 million, with an unrealized loss of approximately $214 million as of September 8, 2008.
- 4Expected impairment charge to be offset by reserve releases from tax settlement agreements.
- 5Guidance reaffirmation will be communicated to analysts and investors during meetings from September 11 to September 24, 2008.
- 6The filing includes a comprehensive Safe Harbor Statement detailing potential risks and uncertainties.
- 7The information furnished under Item 7.01 is not considered 'filed' for purposes of Section 18 of the Exchange Act.